Literature DB >> 14714151

Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis.

Y Orito1, M Morita, K Hori, H Unno, Y Tanji.   

Abstract

To determine the function of the C-terminal region of Bacillus amyloliquefaciens phage endolysin on Pseudomonas aeruginosa lysis, the permeabilization of the outer membrane of P. aeruginosa was analyzed. Glu-15 to His (E15H) and Thr-32 to Glu (T32E) substitutions were introduced into the Bacillus phage endolysin. Neither E15H nor T32E substitution induced enzymatic and antibacterial activities. These two, Glu-15 and Thr-32, were considered to be the active center of the enzyme. The addition of purified E15H and T32E proteins to P. aeruginosa cells induced the release of periplasmic beta-lactamase from the cells, indicating that both proteins enhance permeabilization of the outer membrane. However, the addition of E15H and T32E proteins to P. aeruginosa cells did not induce the release of cytoplasmic ATP from the cells. These results indicate that the antibacterial activity of the endolysin requires both the C-terminal enhancement of the permeabilization of the P. aeruginosa outer membrane and N-terminal enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14714151     DOI: 10.1007/s00253-003-1522-1

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  16 in total

1.  The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.

Authors:  Shuang Wang; Jingmin Gu; Meng Lv; Zhimin Guo; Guangmou Yan; Ling Yu; Chongtao Du; Xin Feng; Wenyu Han; Changjiang Sun; Liancheng Lei
Journal:  J Microbiol       Date:  2017-01-26       Impact factor: 3.422

2.  Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.

Authors:  Assaf Raz; Anna Serrano; Anaise Hernandez; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

Review 3.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

Review 4.  Antimicrobial bacteriophage-derived proteins and therapeutic applications.

Authors:  Dwayne R Roach; David M Donovan
Journal:  Bacteriophage       Date:  2015-06-23

5.  New sub-family of lysozyme-like proteins shows no catalytic activity: crystallographic and biochemical study of STM3605 protein from Salmonella Typhimurium.

Authors:  Karolina Michalska; Roslyn N Brown; Hui Li; Robert Jedrzejczak; George S Niemann; Fred Heffron; John R Cort; Joshua N Adkins; Gyorgy Babnigg; Andrzej Joachimiak
Journal:  J Struct Funct Genomics       Date:  2013-04-10

6.  Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.

Authors:  Maarten Walmagh; Yves Briers; Silvio Branco dos Santos; Joana Azeredo; Rob Lavigne
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

7.  Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.

Authors:  Roberto Vázquez; Ernesto García; Pedro García
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

8.  Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria.

Authors:  Hongling Dong; Chaoyang Zhu; Jingyi Chen; Xing Ye; Yu-Ping Huang
Journal:  Front Microbiol       Date:  2015-11-24       Impact factor: 5.640

9.  Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.

Authors:  Shih-Yi Peng; Ren-In You; Meng-Jiun Lai; Nien-Tsung Lin; Li-Kuang Chen; Kai-Chih Chang
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

Review 10.  Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.

Authors:  Roberto Vázquez; Ernesto García; Pedro García
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.